Carbonic anhydrase inhibitors induce elevations in human whole-blood zinc levels
A. M. Walker, C. Arrigg, E. Hertzmark and D. L. Epstein
The use of carbonic anhydrase inhibitors (CAIs) was associated with mean
increases in whole-blood zinc levels of 82 micrograms/dL and 70
micrograms/dL, respectively, in a cross-sectional survey and in a
prospective study of patients with glaucoma. The time course of the
increase suggests that CAIs induce reticulocyte synthesis of carbonic
anhydrase.